Buprenorphine Prescribing for Opioid Use Disorder in Primary Care

The X-Waiver is gone! This educational activity will show you how to incorporate buprenorphine prescribing for opioid use disorder into your clinical practice.

Rhode Island Specific: This course qualifies for 0.5 hours of risk management credit.

This course can be counted toward the DEA licensure training requirement as noted in their 3/27/2023 communication. Course content aligns with SAMHSA’s content recommendations required by the 2022 Medication Access and Training Expansion (MATE) Act. A total of 8 hours is required.

Learning Objectives

After participating in this educational initiative, the learner should be better able to:

  • Identify the difference between opioid dependence and opioid use disorder.
  • Describe the indications for buprenorphine.
  • Describe and apply knowledge of practical considerations for dosing and maintenance.
  • Describe and apply knowledge of precipitated withdrawal and treatment strategies.

Additional Information

Partner: 
The Warren Alpert Medical School of Brown University
Course summary
Available credit: 
  • 0.50 AMA PRA Category 1 Credit™
Course opens: 
01/23/2024
Course expires: 
01/31/2026
Rating: 
0

Available Credit

  • 0.50 AMA PRA Category 1 Credit™
Please login or register to take this course.

This course is offered through The Warren Alpert Medical School of Brown University. 

 

To take this course you will be redirected to The Warren Alpert Medical School of Brown University's website. You must login or create an account with The Warren Alpert Medical School of Brown University in order to complete this activity. 

 

Mocingbird works to provide curated, high quality content to our users. Have a suggestion? Want to partner with us? Get in touch!